138 related articles for article (PubMed ID: 15454494)
1. Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells.
Frelin C; Imbert V; Griessinger E; Peyron AC; Rochet N; Philip P; Dageville C; Sirvent A; Hummelsberger M; Bérard E; Dreano M; Sirvent N; Peyron JF
Blood; 2005 Jan; 105(2):804-11. PubMed ID: 15454494
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
3. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Grosjean-Raillard J; Tailler M; Adès L; Perfettini JL; Fabre C; Braun T; De Botton S; Fenaux P; Kroemer G
Oncogene; 2009 Feb; 28(8):1099-109. PubMed ID: 19079347
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products.
Ichikawa H; Takada Y; Murakami A; Aggarwal BB
J Immunol; 2005 Jun; 174(11):7383-92. PubMed ID: 15905586
[TBL] [Abstract][Full Text] [Related]
5. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
6. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells.
Takada Y; Andreeff M; Aggarwal BB
Blood; 2005 Jul; 106(2):641-9. PubMed ID: 15811958
[TBL] [Abstract][Full Text] [Related]
7. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.
Lagadec P; Griessinger E; Nawrot MP; Fenouille N; Colosetti P; Imbert V; Mari M; Hofman P; Czerucka D; Rousseau D; Berard E; Dreano M; Peyron JF
Br J Cancer; 2008 Jan; 98(2):335-44. PubMed ID: 18182997
[TBL] [Abstract][Full Text] [Related]
9. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
[TBL] [Abstract][Full Text] [Related]
11. Dual role of NF-kappaB in apoptosis of THP-1 cells during treatment with etoposide and lipopolysaccharide.
Sato K; Taniguchi T; Suzuki M; Shinohara F; Takada H; Rikiishi H
Leuk Res; 2004 Jan; 28(1):63-9. PubMed ID: 14630082
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
[TBL] [Abstract][Full Text] [Related]
13. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic cells.
Frelin C; Imbert V; Griessinger E; Loubat A; Dreano M; Peyron JF
Oncogene; 2003 Nov; 22(50):8187-94. PubMed ID: 14603259
[TBL] [Abstract][Full Text] [Related]
14. AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells.
Griessinger E; Imbert V; Lagadec P; Gonthier N; Dubreuil P; Romanelli A; Dreano M; Peyron JF
Leukemia; 2007 May; 21(5):877-85. PubMed ID: 17330097
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
[TBL] [Abstract][Full Text] [Related]
16. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types.
Majumdar S; Aggarwal BB
Oncogene; 2003 Feb; 22(8):1206-18. PubMed ID: 12606947
[TBL] [Abstract][Full Text] [Related]
17. An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.
Hu X; Janssen WE; Moscinski LC; Bryington M; Dangsupa A; Rezai-Zadeh N; Babbin BA; Zuckerman KS
Cancer Res; 2001 Aug; 61(16):6290-6. PubMed ID: 11507084
[TBL] [Abstract][Full Text] [Related]
18. Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.
Jourdan M; Moreaux J; Vos JD; Hose D; Mahtouk K; Abouladze M; Robert N; Baudard M; Rème T; Romanelli A; Goldschmidt H; Rossi JF; Dreano M; Klein B
Br J Haematol; 2007 Jul; 138(2):160-8. PubMed ID: 17542984
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells.
Estrov Z; Shishodia S; Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Aggarwal BB
Blood; 2003 Aug; 102(3):987-95. PubMed ID: 12689943
[TBL] [Abstract][Full Text] [Related]
20. Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts.
Baumgartner B; Weber M; Quirling M; Fischer C; Page S; Adam M; Von Schilling C; Waterhouse C; Schmid C; Neumeier D; Brand K
Leukemia; 2002 Oct; 16(10):2062-71. PubMed ID: 12357358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
